Should Gritstone Bio be a part of your Investment Portfolio?
Gritstone Bio, Inc. (NASDAQ: GRTS), formerly known as Gritstone Oncology, is a clinical-stage biotechnology company developing targeted immunotherapies for a range of diseases in the cancer and infectious disease space. The Company’s approach is based on leveraging the inherent abilities of the immune system to...
